Hepatic Tuberculosis: What to Do When Standard Antitubercular Therapy Has Not Achieved the Expected Clinical Response

Hepatic tuberculosis is managed with a structured course of antitubercular therapy. When the standard first-line regimen is completed but the expected clinical goals are not reached, a modified approach is required.

Previous treatment — failure condition The standard regimen — a 2-month intensive phase of four drugs (Rifampicin, Isoniazid, Ethambutol, and Pyrazinamide) followed by a 4-month continuation phase of Rifampicin and Isoniazid — did not achieve the expected clinical response within the monitored 4–6 week window: resolution of symptoms, weight gain, improving haemoglobin, and a fall in C-reactive protein (CRP) levels.

Next-line approach — partial overview In cases of recurrent disease, drug resistance, or serious illness, the continuation phase is modified to include an extended antitubercular combination. The complete regimen — specifying which agents are used together and under exactly which conditions — is available in the full structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

In cases of recurrent disease, drug resistance, or serious illness Continue ethambutol

View source ↗